Baxter International (BAX) EBITDA Margin (2009 - 2026)

Baxter International (BAX) has 18 years of EBITDA Margin data on file, last reported at 2.44% in Q1 2026.

• EBITDA Margin for Q1 2026 came in at 2.44%, down 495.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 4.77% (down 502.0% YoY), and the FY2025 annual result was 2.74%, down 287.0% from the prior year.
• EBITDA Margin declined to 2.44% in Q1 2026 per BAX's latest filing, from 7.39% in the prior quarter.
• Over five years, EBITDA Margin peaked at 100.38% in Q3 2023 and troughed at 79.8% in Q3 2022.
• A 5-year average of 5.75% and a median of 4.93% in 2022 frame the typical range for EBITDA Margin.
• The sharpest annual moves came in 2022 and 2023: EBITDA Margin slumped 9570 bps in 2022, then jumped 18019 bps in 2023.
• A 5-year view of EBITDA Margin shows it stood at 8.33% in 2022, then surged by 384 bps to 23.67% in 2023, then soared by 47 bps to 34.83% in 2024, then tumbled by 79 bps to 7.39% in 2025, then tumbled by 67 bps to 2.44% in 2026.
• Business Quant data shows BAX's EBITDA Margin at 2.44% in Q1 2026, 7.39% in Q1 2025, and 34.83% in Q4 2024.